Journal of Medicinal Chemistry p. 854 - 861 (1990)
Update date:2022-08-05
Topics:
Pavia
Lobbestael
Taylor
Hershenson
Miskell
A series of N-phenyl-N'-pyridinylureas was examined for anticonvulsant activity. Extensive structure/activity investigations revealed optimal activity in the N-(2,6-disubstituted-phenyl)-N'-(4-pyridinyl)urea series, with 37 exhibiting the best overall anticonvulsant profile. Compound 37 was effective against seizures induced by maximal electroshock but did not protect mice from clonic seizures produced by the convulsant pentylenetetrazol. The overall pharmacological profile suggests that 37 would be of therapeutic use in the treatment of generalized tonic-clonic and partial seizures. Compound 37 was selected for Phase 1 clinical trials.
View MoreHangzhou jls Flame Retardants Chemical Co.,Ltd
Contact:+86-571-87250387/87250386
Address:MOGANSHAN RODA 1418# SHANGCHENG INDUSTRIAL PARK
Contact:86-516-66656369
Address:The west road of Huaihai, Xuzhou, China
Contact:+86-10-67147360/67107388
Address:No.18 Guangming Zhongjie, Chongwen District, Beijing, 100061, China
Xi'an caijing Opto-Electrical Science & Technology Co., LTD
Contact:+86-29-88294447
Address:NO.168 Zhangba Rd. East, Xi'an, P.R.China
TIANJIN NORTH JINHENG CHEMICAL PLANT.
Contact:0086-22-59952083
Address:DongShigu Country In JiXian TianJin China
Doi:10.1007/BF00764666
(1989)Doi:10.1021/acs.jmedchem.6b00397
(2016)Doi:10.1021/jo00293a027
(1990)Doi:10.1016/j.bmcl.2011.05.040
(2011)Doi:10.1021/jo101173t
(2010)Doi:10.1016/j.bmcl.2016.03.077
(2016)